# Carrie D. Swartz, M.D. – FDA Inspection, Nov 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/carrie-d-swartz-md/f780b85d-ed2d-4146-bff6-2dec74bf5ee6
Source feed: FDA_Inspections

> FDA inspection 1254831 of Carrie D. Swartz, M.D., November 22, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254831
- Company Name: Carrie D. Swartz, M.D.
- Inspection Date: 2024-11-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Denver District Office
- Citation Count: 1

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/audrey-j-yarbrough/1bab3d1a-3246-451e-96fb-4ce52185e850)

Company: https://www.keypedia.com/companies/carrie-d-swartz-md/1c5e3b95-5de2-49b1-8053-b6eda477c4e7

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face